Clostridium difficile infection: Description of NAP1/027 and non NAP1/027 strains in a high complexity center in Cali, Colombia, 2012-2015
Abstract
Introduction: Clostridium difficile causes nosocomial infections leading to high morbidity and mortality. The NAP1/027 strain is associated with a higher toxin production and disease severity, which increases the load of the disease.
Objective: To describe the epidemiology of the infections associated with C. difficile and the characteristics related to the NAP1/027 strain.
Materials and methods: This was an observational study based on the revision of clinical registries of patients with fecal samples that were positive for C. difficile identified by the Xpert test™ between 2012 and 2015 in a high complexity institution. The severity of the disease was evaluated by means of the ATLAS score.
Results: We included 42 infected cases, 9 of which were positive for the NAP1/027strain. The use of antibiotics previous to the infection for more than seven days was more frequent in patients with negative results for NAP1/027. The duration of diarrhea in half of the patients was longer than five days and there were no differences according to the type of strain (p>0.05). Positive cases for the NAP1/027 strain were characterized by presenting fetid and bloody stools. The severity of the infection was similar between the groups.
Conclusions: In Colombia, the NAP1/027 strain circulates without significant clinical differences, which could be due to the limited number of patients. Nevertheless, the existence of NAP1/027 should alert physicians and health institutions because of its high association with severity and mortality.
Downloads
References
Maggil S, Edwards J, Stat M, Bamberg W, Beldavs Z, Dumyati G, et al. Multistate pointprevalence survey of health care-associated infections. N Engl J Med. 2014;370:1198-208. https://doi.org/10.1056/NEJMoa1306801
Leffler D, Lamont T. Clostridium difficile infections. N Engl J Med. 2015;372:1539-48. https://doi.org/10.1056/NEJMra1403772
Zea JW, Salazar CL. Enfermedad asociada a Clostridium difficile: prevalencia y diagnóstico por laboratorio. Infectio. 2012;16:211-22. https://doi.org/10.1016/S0123-9392(12)70016-4
Depestel DD, Aronoff DM. Epidemiology of Clostridium difficile infection. J Pharm Pract. 2013;26:464-75. https://doi.org/10.1177/0897190013499521
Rodríguez-Pardo D, Almirante B, Bartolome RM, Pomar V, Mirelis B, Navarro F, et al. Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: Results of a hospital-based study in Barcelona, Spain. J Clin Microbiol. 2013;51:1465-73. https://doi.org/10.1128/JCM.03352-12
Magee G, Strauss ME, Thomas SM, Brown H, Baumer D, Broderick KC. Impact of Clostridium difficile-associated diarrhea on acute care length of stay, hospital costs, and readmission: A multicenter retrospective study of inpatients, 2009-2011. Am J Infect Control. 2015;43:1148-53. https://doi.org/10.1016/j.ajic.2015.06.004
See I, Mu Y, Cohen J, Beldavs ZG, Winston LG, Dumyati G, et al. NAP1 strain type predicts outcomes from Clostridium difficile infection. Clin Infect Dis. 2014;58:1394-400. https://doi.org/10.1093/cid/ciu125
Morfin-Otero R, Garza-González E, Aguirre-Díaz SA, Escobedo-Sánchez R, Esparza-Ahumada S, Pérez-Gómez HR, et al. Clostridium difficile outbreak caused by NAP1/BI/027 strain and non-027 strains in a Mexican hospital. Braz J Infect Dis. 2016;20:8-13. https://doi.org/10.1016/j.bjid.2015.09.008
Marsh JW, Arora R, Schlackman JL, Shutt KA, Curry SR, Harrison LH. Association of relapse of Clostridium difficile disease with BI/NAP1/027. J Clin Microbiol. 2012;50:4078-82. https://doi.org/10.1128/JCM.02291-12
Oñate-Gutiérrez J, Villegas M, Correa A. Prevalencia y factores relacionados con la infección por Clostridium difficile en un centro hospitalario de alta complejidad en Cali (Colombia). Infectio. 2017;21:9-14. https://doi.org/10.1016/j.infect.2015.12.002
Gualtero S, Abril LA, Camelo N, Sánchez SD, Silva E, Dávila FA, et al. Características de la infección por Clostridium difficile en una institución de alta complejidad y reporte de la circulación en Colombia de la cepa hipervirulenta NAP17027. Biomédica. 2017;37:7-12. https://doi.org/10.7705/biomedica.v37i4.3244
Otero-Regino W, González A, Gómez-Zuleta M. Prevalencia de diferentes tipos de colitis en personas adultas mayores. Revista Colombiana de Gastroenterología. 2009;24:272-8.
Becerra MG, Ospina S, Atehortúa SL, Berbesi DY. Factores de riesgo para la infección por Clostridium difficile. Infectio. 2011;15:220-6.
Cohen S, Gerding D, Johnson S, Kelly C, Loo V, McDonald L, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431-55. https://doi.org/10.1086/651706
Hernández-García R, Garza-González E, Miller M, Arteaga-Muller G, Galván-de los Santos AM, Camacho-Ortiz A. Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in México. Braz J Infect Dis. 2015;19:399-402. https://doi.org/10.1016/j.bjid.2015.05.005
Miller MA, Louie T, Mullane K, Weiss K, Lentnek A, Golan Y, et al. Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy. BMC Infect Dis. 2013;13:148. https://doi.org/10.1186/1471-2334-13-148
Di X, Bai N, Zhang X, Liu B, Ni W, Wang J,et al. A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile Infection, stratified by disease severity. Braz J Infect Dis. 2015;19:339-49. https://doi.org/10.1016/j.bjid.2015.03.006
Debast S, Bauer M, Kuijper E. European Society of Clinical Microbiology and Infectious Diseases: Update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20(Suppl.2):1-26. https://doi.org/10.1111/1469-0691.12418
Mathur H, Rea MC, Cotter PD, Ross RP, Hill C. The potential for emerging therapeutic options for Clostridium difficile infection. Gut Microbes. 2014;5:696-710. https://doi.org/10.4161/19490976.2014.983768
Some similar items:
- Sandra Milena Gualtero, Lina Alejandra Abril, Nathalia Camelo, Susi Daniela Sanchez, Fabián Antonio Davila, Gerson Arias, Edwin Silva, Ingrid Gissel Bustos, Diego Fernando Josa, Isabel Cristina Torres, Luis Carlos Zambrano, María José Pareja, Characteristics of Clostridium difficile infection in a high complexity hospital and report of the circulation of the NAP1/027 hypervirulent strain in Colombia , Biomedica: Vol. 37 No. 4 (2017)
- María Fernanda Gutiérrez, Sandra Moreno, Mónica Viviana Alvarado, Andrea Bermúdez, DNA sequence analysis indicates human origin of rotavirus and hepatitis A virus strains from western Colombia , Biomedica: Vol. 29 No. 2 (2009)
- Daniel Eduardo Henao, Fabián Alberto Jaimes, Evidence-based medicine: an epistemological approach , Biomedica: Vol. 29 No. 1 (2009)
- Luz Elena Velásquez, Catalina Gómez, Erika Valencia, Laura Salazar, Eudoro Casas, Paragonimosis in the peri-urban zone of Medellín, Antioquia , Biomedica: Vol. 28 No. 3 (2008)
- Ana Luz Galván, Katherine Bedoya, Martha Nelly Montoya, Jorge Botero, Isolate of Encephalitozoon intestinalis from stools of a Colombian patient with AIDS , Biomedica: Vol. 28 No. 3 (2008)
- Ana María Perilla, Camilo González, Sandra Liliana Valderrama, Natasha Vanegas, Bibiana Chavarro, Luis Carlos Triana, José Roberto Támara, Carlos Arturo Álvarez, Necrotizing pneumonia by community-acquired, methicillin-resistant Staphylococcus aureus in Colombia , Biomedica: Vol. 29 No. 4 (2009)
- Juan P. Gómez, Juan C. Quintana, Patricia Arbeláez, Jorge Fernández, Juan F. Silva, Jacqueline Barona, Juan C. Gutiérrez, Abel Díaz, Rafael Otero, Tityus asthenes scorpion stings: epidemiological, clinical and toxicological aspects , Biomedica: Vol. 30 No. 1 (2010)
- Juan Gabriel Piñeros, Malaria and social health determinants: a new heuristic framework from the perspective of Latin American social medicine , Biomedica: Vol. 30 No. 2 (2010)
- Eliana Parra, Elizabeth Castañeda, Jaime Moreno, Identification of Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitidis by polymerase chain reaction , Biomedica: Vol. 27 No. 3 (2007)
- Richard Hoyos, Lisandro Pacheco, Luz Adriana Agudelo, German Zafra, Pedro Blanco, Omar Triana, Seroprevalence of Chagas disease and associated risk factors in a population of Morroa, Sucre , Biomedica: Vol. 27 No. 1esp (2007): Enfermedad de Chagas
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
